ArticlePloS one2013

Evaluation of the validity of preemptive therapy against cytomegalovirus disease based on antigenemia assay with a cutoff of 20 positive cells per two slides.

Kana Sakamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.